“…Up to now, severalm agnetic polymeric formulations have been developed for the targeted specific delivery of platinum drugs. [13] Among them, polysaccharides (dextran, [14] alginate, [15] and carboxymethylcellulose (CMC) [16] )s eem to be interesting candidates for stabilizing MNPs. In general, polysaccharides are biocompatible polymers and, moreover,c arboxylated polysaccharides (alginate and CMC) can offer free carboxy groups for both the loading of cisplatin molecules and the binding of other molecules possessing ap rimary or secondary amine group, such as drugs, proteins, and fluorescent labels.…”